NCT05503927View on ClinicalTrials.gov

A Study to Evaluate the Safety of Exposure to Wegovy During Pregnancy

Enrolling by invitationOBSERVATIONAL

Enrollment

1,139

Participants

Timeline

Start Date

January 2, 2023

Primary Completion Date

August 15, 2027

Study Completion Date

August 15, 2027

Conditions

PregnancyObesityOverweight

Interventions

OTHER

No Intervention

This is a non-interventional study, therefore no intervention is used.

Trial Locations (1)

08540

Novo Nordisk Investigational Site, Princeton

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY